Author: Betsy Bates
Edition:
Binding: Digital
ISBN: B0008FA42Q
Edition:
Binding: Digital
ISBN: B0008FA42Q
Teriparatide shown to strengthen bone: awaiting FDA approval for osteoporosis. (Clinical Rounds).(parathyroid hormone): An article from: Family Practice News
This digital document is an article from Family Practice News, published by International Medical News Group on April 15, 2002. Get Teriparatide shown to strengthen bone: awaiting FDA approval for osteoporosis. (Clinical Rounds).(parathyroid hormone): An article from diet books 2013 for free.
The length of the article is 552 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Teriparatide shown to strengthen bone: awaiting FDA approval for osteoporosis. (Clinical Rounds).(parathyroid hormone)
Author: Betsy Bates
Publication: Family Practice News (Magazine/Journal)
Date: April 15, 2002
Publisher: Check Teriparatide shown to strengthen bone: awaiting FDA approval for osteoporosis. (Clinical Rounds).(parathyroid hormone): An article from our best diet books for 2013. All books are available in pdf format and downloadable from rapidshare, 4shared, and mediafire.

Teriparatide shown to strengthen bone: awaiting FDA approval for osteoporosis. (Clinical Rounds).(parathyroid hormone): An article from Free
The length of the article is 552 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase (parathyroid hormone)
Author: Betsy Bates
Publication: Family Practice News (Magazine/Journal)
Date: April 15, 2002
Publisher:
No comments:
Post a Comment